Arnoud Huisman Email and Phone Number
Arnoud Huisman work email
- Valid
- Valid
- Valid
- Valid
- Valid
Arnoud Huisman personal email
Executive leader with 30 years experience and expertise in a wide variety of life sciences area’s: Oncology, consortia building, CRO, Pharmaceutical, Biotech, Functional Food, Diagnostics and Medical Devices. Key roles in M&A and Venture Capital deal making. Driven by transforming Science into Value. Key leadership roles as Chairman of the Board, CEO, CCO, CSO and (Senior) Vice President in account, line, marketing, scientific and operational management for local and global companies. Success is driven by focus, commitment, getting it done, organizational talent and an intrinsic motivation to increase people’s personal performance. Board member of ACRON (Association CRO Netherlands), DCTF (Dutch Clinical Trial Foundation), Delphi Bioscience, EUCROF (European CRO Federation), Oncode Accelerator. Member of several Executive Steering Committees, both for large global pharma as biotech companies in Europe and USA. Managed several Phase I-IIa clinics in The Netherlands (including Clinical Operations, Project Management, Science, QA and Data Support, as well as ensuring GCP compliance) with succesfull delivery of appr. 250 phase I and IIa trials. P&L responsibility with record high EBITDA %. Leading role in several international mergers and acquisitions, including organizational integration.
-
Ceo And Chairman Of The BoardOncode Accelerator Jan 2024 - PresentTo accelerate the development of safe, personalised and effective therapies, Oncode Accelerator places the patient at the center of the preclinical development pipelines. We do this by fully utilising the power of 3 innovation platforms: well defined patient cohorts, organoid models and artificial intelligence. This will drive improved predictions of the safety and effectiveness of new therapies for specific patient groups. -
SciencetovalueLife Sciences Consultancy & Interim Management May 2016 - Present- Making things real, make it happen and make it better every day.- Strategic Deadlock that needs an experienced external look.- Disconnect between operations and business development that needs to be fixed/aligned- Scientific oriented organisation that needs to be transformed into a client focussed andprofitable business by combining science and commercial/business development.
-
Chief Strategy Officer And Managing DirectorNuvisan The Science Cro Aug 2020 - Dec 2023Neu-Ulm, DeThe INNOVATION CAMPUS BERLIN is a dynamic contract research institute with about 500 employees founded by the acquisition of a complete research unit from Bayer.Decades of experience and top-notch expertise in the field of early pharmaceutical research combined with the spirit of a medium-sized, family owned company create an innovative campus of excellence for early Pharma research. -
Chief Executive OfficerCc Diagnostics Sep 2017 - Nov 2021Groningen, NlCervical cancer is a worldwide problem; with regular and decent screening it is mostly preventable. With regular screening, the early precancerous changes in cervical cells can be detected and treated. CC Diagnostics aims to develop and market a superior method for diagnosing early stages of cervical cancer. With this accurate test implemented in national cervical cancer screening programs (or sold on the private market), a big part of unneeded follow-up diagnostic can be prevented. As a result, healthcare costs and women’s stress will be reduced. With this method of testing, CC Diagnostics can play its part in making sure there is accurate and participative cervical screening available for every woman.www.cc-diagnostics.com -
Chief Commercial OfficerCc Diagnostics Mar 2017 - Sep 2017Groningen, NlCC Diagnostics aims to develop and market a superior method for diagnosing early stages of cervical cancer. With this accurate test implemented in national cervical cancer screening programs (or sold on the private market), a big part of unneeded follow-up diagnostic can be prevented. As a result, healthcare costs and women’s stress will be reduced. With this method of testing, CC Diagnostics can play its part in making sure there is accurate and participative cervical screening available for every woman. -
Chief Executive OfficerIova Biopharmaceuticals Jan 2020 - Jun 2020Utrecht, Nlwww.iovabiopharmaceuticals.comIOVA started in September 2018 and is currently developing one biopharmaceutical product: MICROLYSE. MICROLYSE enzymatically breaks down blood clots in small blood vessels (i.e. the microvasculature), for which to date, no specific treatment exists. IOVA pursues to receive market authorization for an orphan disease named Thrombotic Thrombocytopenic Purpura (TTP) that is characterized by life threatening attacks of microvascular thrombosis. However, MICROLYSE has the capacity to target all forms of microvascular thrombosis and could also be applied in early-stage macrovascular thrombosis as seen in heart attacks and stroke. In vivo validation in TTP in mice is expected early 2020. Additionally, IOVA is actively exploring the applicability of MICROLYSE in acute ischemic stroke.At IOVA, we are determined to change the future of microvascular thrombosis. -
Chief Commercial OfficerJulius Clinical Mar 2018 - Feb 2020Zeist, Utrecht, NlJulius Clinical is the research organisation that is able to combine the latest scientific insights with operational excellence to find credible, creative, cost-effective solutions for clinical trials.We have a strong and committed network of academic leaders and investigators around the world in a variety of therapeutic areas.We are partners with key medical centers, academic leaders, and investigators which ensure commitment and adherence to study guidelines of local clinicians all around the world.We have access to sites and eligible patients for clinical trials.We offer the peer-to-peer leadership model: enhanced recruitment and retention through leadership of investigators in our networks. -
Commercial Development ExecutiveBiotrial Oct 2016 - Sep 2018Europe And North America, FrBiotrial's mission is to provide our sponsors with high-quality pharmacology services, adding value to their projects by working together and meeting all needs throughout the development process. To ensure this mission, Biotrial advocates controlled extension of its facilities and prides itself in developing long-standing relationships with our sponsors.With experience gained from over 25 years activity, Biotrial has established flexible and efficient working practices ensuring client satisfaction – workflow tailor-made to keep to deadlines and budget terms as well as rigorous quality control covering every detail. The active participation of key members of staff in all projects ensures the quality of our services. -
Consultant Human Challenge ModelsNizo Aug 2016 - Jun 2017Ede, Gelderland, NlYou’ve come to the world’s leading company in contract research for better food and health. NIZO food research is a private and independent company. We are one of the most advanced R&D centers in the world and bring the latest food technologies to life in our food grade processing centre. Our focus is on the development and applications of innovations for the global food industry and related markets. Our customers value their gains in product quality, sustainability, cost effectiveness and speed to market. We are continuously looking for new ways of improving food products, and at the same time quality of life. Our headquarters are in Ede, the Netherlands -
Director, Interim CeoNano Fiber Matrices B.V. Jun 2016 - Jan 2017Groningen, Nl -
Senior Vice President Alliance ManagementPra Health Sciences Apr 2015 - Mar 2016Raleigh, North Carolina, Us -
Senior Vice President Global Business Development Early Development ServicesPra Health Sciences Jan 2014 - Mar 2015Raleigh, North Carolina, Us -
Vice President Global Business Development Early Development ServicesPra Health Sciences Jun 2011 - Dec 2013Raleigh, North Carolina, UsLeading the Global Business Development Team for Early Development Services: First in Human to Proof of Concept and Patient Pharmacology, including bio-analytical. Global responsibility for all clients. Member of several Executive Steering Committees, both major pharma and biotech based in EU and USA. Has sold over $750 mio in phase I studies. -
Vice President ClinicPra Health Sciences Mar 2007 - May 2011Raleigh, North Carolina, UsLeading the PRA Phase I clinics in The Netherlands: 140 beds, from NBA to CSR including Science, Project Management, Operations, Data Support and Quality Management. In total 300 FTE. -
Chair Early Phase Working GroupEucrof Jan 2012 - Oct 2014
-
Board MemberDelphi Bioscience Jan 2013 - Sep 2014Delphi Bioscience is a leading life sciences company that develops innovative health screening solutions for women. Delphi Bioscience aims to give under-screened women access to reliable and user-friendly cervical cancer screening as well as screening for other vaginal and cervical infections. With reliable screening, many cervical cancer and other vaginal and cervical infections can be prevented among women in a cost-effective manner.The starting point for Delphi Bioscience solutions is our unique self-sampling device, Delphi Screener, which can be used by women themselves, or their doctors, to collect reliable cervico-vaginal samples without the need for inserting a speculum during a pelvic exam.
-
Board MemberDutch Clinical Trial Foundation Jan 2011 - Jan 2012De Dutch Clinical Trial Foundation, oftewel DCTF, berust op een sectorbreed samenwerkingsverband dat het (inter)nationale bedrijfsleven wil verbinden aan de Nederlandse medische kennisinfrastructuur op het gebied van klinisch onderzoek. DCTF is opgericht omdat Nederland, ondanks de hoge kwaliteit van het medische onderzoek in ziekenhuizen en huisartsenpraktijken, niet voldoende meedeelt in de wereldwijde toename van klinisch onderzoek. Dit onderzoek met mensen is essentieel voor de ontwikkeling van nieuwe en betere medicijnen, vaccins en medische hulpmiddelen, zoals pacemakers en kunstgewrichten. Gesignaleerde oorzaken van deze stagnatie zijn o.a. het onvoldoende naleven van procedures voor het verkrijgen van nodige toestemmingen en werving van patiënten. De missie van de stichting is het behouden en bevorderen van de concurrentiepositie van Nederland en daarmee innovatie op het gebied van de gezondheidszorg te stimuleren. De doelstellingen hierbij zijn:Verbeterde toegang van patiënten tot clinical trials en daardoor een verhoogde participatieEen toename van klinisch onderzoek en behoud/verhoging Nederlands marktaandeelVerhoogde deskundigheid en opleidingsniveau van zorgprofessionals
-
Board MemberAcron Mar 2008 - Nov 2011Zeist, Utrecht, NlSince its establishment in 1995 ACRON has grown to a professional organisation representing the interests of over 35 CRO's in liaison with National Authorities, Regulatory Bodies and other organisations directly or indirectly involved in Clinical Research.ACRON's main activities consist of:Participation in various platforms and organisations focusing at the promotion and improvement of the conditions for the conduct of Clinical Research, both on a national and international levelOrganisation of Symposia and WorkshopsOrganisation of regular meetings with its members In addition various ACRON working committees are dealing with specific topics for improvement of the Clinical Research environment in the Netherlands. -
Director Marketing & Business DevelopmentPharma Bio Research/Pra Mar 2004 - Feb 2007
-
Director Marketing & SalesWyeth Pharmaceuticals Bv 2002 - 2004New York, New York, Usresponsible for all marketing and sales activities for Wyeth Netherlands
Arnoud Huisman Skills
Arnoud Huisman Education Details
-
Vrije Universiteit Amsterdam (Vu Amsterdam)Human Movement Sciences
Frequently Asked Questions about Arnoud Huisman
What company does Arnoud Huisman work for?
Arnoud Huisman works for Oncode Accelerator
What is Arnoud Huisman's role at the current company?
Arnoud Huisman's current role is Life Science Executive building Value from Science.
What is Arnoud Huisman's email address?
Arnoud Huisman's email address is ar****@****lue.com
What schools did Arnoud Huisman attend?
Arnoud Huisman attended Vrije Universiteit Amsterdam (Vu Amsterdam).
What skills is Arnoud Huisman known for?
Arnoud Huisman has skills like Clinical Trials, Cro, Pharmaceutical Industry, Clinical Research, Biotechnology, Life Sciences, Clinical Development, Lifesciences, Oncology, Drug Development, Pharmacology, Regulatory Affairs.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial